Inactive Instrument

Analyst Reco. Essity AB Other OTC

Equities

Global markets live: AstraZeneca, Apple, Meta, Microsoft, Cisco...	06-17
ESSITY : EPS cut (2023: -9.6%, 2024: -1.3%)	06-01
ESSITY : Q1 24: Strong margin delivery despite soft volumes	05-03
ESSITY : Multiple silver linings although the headline Q4 23 disappoints	01-25
ESSITY : EPS cut (2023: +15.3%, 2024: -16.9%)	01-22
ESSITY : Q3 23: Falling input costs should sustain strong margin traction	11-02
ESSITY : Essity Q2 23: Unwarranted sell-off, margin recovery clearly intact	21/07/23
ESSITY : Strong Q1 23 underpinned by broad-based momentum	27/04/23
ESSITY : Q4 22: Past a margin trough?	27/01/23
ESSITY : Low price elasticity makes up for weak Q3 22 earnings	02/11/22
ESSITY : Q2 21: the beat isn’t good enough...	22/07/22
ESSITY : Q1 22: Pricing execution stands out in face of cost headwinds	23/04/22
China, rate hike worries push European stocks to 1-month closing low	22/04/22	RE
ESSITY : Q4/FY 21: input inflation offsets top-line momentum	31/01/22
ESSITY : Q3 21: Broadening cost inflation will require more price increases	25/10/21
ANALYST RECOMMENDATIONS : GlaxoSmithKline, Qualcomm, State Street, Tate & Lyle, Virgin Money UK...	19/07/21
ESSITY : Q2 21: steep margin headwinds	16/07/21
Exane BNP Paribas European CEO Conference	07/06/21	FA
Berenberg US Conference	17/05/21	FA
ESSITY : Q1 21 miss precedes margin challenges	23/04/21

No results for this search

ESSITY : EPS cut (2023: -9.6%, 2024: -1.3%)

June 01, 2024 at 04:22 pm